Missolapola

Frm.	Topic / Post	Postinfo	#Aanb.
GAL	Galapagos december 2020 [quote alias=Kelewan id=12951626 date=202011301708]Het is weer wat anders, Sints pieten lopen dit ...	Missolapola 30 nov 2020 22:50	12
GAL	Galapagos december 2020 www.fsma.be/nl/van-de-stolpe-onno-65www.fsma.be/nl/hoekema-andre-46...	Missolapola 17 dec 2020 22:33	7
GAL	Bericht van CEO aan Forum Proficiat Team Galapagos en bedankt voor het mooie jaar dat jullie ondertussen al bezorgd hebben aan...	Missolapola 10 dec 2019 15:27	6
GAL	Galapagos februari 2019 Mooi artikel in De Tijd : hoe alles kan veranderen na overname door een farmagigant....“Een ja...	Missolapola 16 feb 2019 08:59	6
AFF	Forum Affimed geopend Iedereen hier een vruchtbaar beursjaar 2024 gewenst! Voor de investeerders in deze sector kan het t...	Missolapola 2 jan 2024 11:41	5

Forumberichten

Frm.	Topic / Post	Postinfo
ANA	Forum Anavex Life Sciences Corp geopend Heb het even nagekeken: op 21/9/20 aangekocht op gemiddeld 4,2 USD en op 7/7/21 verkocht op gemiddeld 25,68 USD. En op 3/1/23 terug aangekocht op 9,64 USD. Nu afwachten hoe de rit zal zijn. Het sen...	Missolapola 24 dec 2024 11:08
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-INHBE for the Treatment of Obesity - ARO-INHBE targets a known pathway that signals the body to store fat in adipose tissue- ...	Missolapola 23 dec 2024 14:18
AFF	Forum Affimed geopend Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)AFM28, a bispecific, tetravalent innate cell engager (ICE®) targeting CD12...	Missolapola 9 dec 2024 19:41
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity- In preclinical studies, investigational ARO-ALK7 silenced Activin rec...	Missolapola 3 dec 2024 14:19
ARR	Forum Arrowhead Research geopend Ben ook aan het wachten op AFMD :-)Heb naast ARWR en AFMD ook nog AVXL in de biotech portefeuille...	Missolapola 26 nov 2024 15:08
ANA	Forum Anavex Life Sciences Corp geopend NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for...	Missolapola 26 nov 2024 13:39
ARR	Forum Arrowhead Research geopend PASADENA, Calif.--(BUSINESS WIRE)--Nov. 26, 2024-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT...	Missolapola 26 nov 2024 13:07
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals Announces Global License and Collaboration Agreement with Sarepta Therapeutics for Multiple Clinical and Preclinical Programs- Upon closing, Arrowhead will receive $825 m...	Missolapola 26 nov 2024 13:06
AFF	Forum Affimed geopend Hier een GAK van $8,79.Fingers crossed!...	Missolapola 26 nov 2024 07:18
AFF	Forum Affimed geopend x.com/bearbull_trader/status/18596281...‘I went through the updated (14th Nov 2024) institutional holders list of Affimed shares $AFMDWe might be in for a big surprise (ho...	Missolapola 21 nov 2024 20:27
AFF	Forum Affimed geopend Affimed Reports Third Quarter 2024 Financial Results Business UpdateAFM24 combination with atezolizumab: The non-small cell lung cancer (NSCLC) EGFR wild-type (EGFRwt) cohort completed enrollm...	Missolapola 14 nov 2024 12:58
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for PlozasiranSeptember 10, 2024PALISADE Phase 3 results demonstrate plozasiran reduced triglycerides by 80% from baseline...	Missolapola 10 sep 2024 13:39
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals to Advance Two New RNAi-Based Obesity Candidates, ARO-INHBE and ARO-ALK7, Into Clinical StudiesAugust 14, 2024PDF Version- Company hosting an obesity/metabolic RD ...	Missolapola 14 aug 2024 20:04
AFF	Forum Affimed geopend Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant CohortIn...	Missolapola 1 jun 2024 19:19
AFF	Forum Affimed geopend Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung CancerEfficacy and safety of AFM24 in combination with atezolizumab,...	Missolapola 29 mei 2024 13:53
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed HyperlipidemiaMay 29, 2024PDF Version- Zodasiran significantly reduced triglycerides and atherogenic trigl...	Missolapola 29 mei 2024 13:49
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed HyperlipidemiaMay 28, 2024PDF Version- Plozasiran significantly lowered triglyceride levels with commensu...	Missolapola 28 mei 2024 13:31
AFF	Forum Affimed geopend Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinica...	Missolapola 24 mei 2024 07:42
ARR	Forum Arrowhead Research geopend quote:de tuinman schreef op 15 mei 2024 17:55:[...]Ik heb sinds kort Discord. Heb je tips voor me?Geen extra tips, Tuinman.Het wijst zichzelf, gewoon lezen en er het jouw...	Missolapola 15 mei 2024 19:39
ARR	Forum Arrowhead Research geopend We zijn alvast in goed gezelschap met onze visie ;-)...	Missolapola 15 mei 2024 12:24
AFF	Forum Affimed geopend Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 CongressTreatment with AFM28 innate cell engager (ICE®), ...	Missolapola 14 mei 2024 16:41
ARR	Forum Arrowhead Research geopend Artal Group S.A. Top Holdings and 13F Report (2024)www.marketbeat.com/13f-filings/artal-...Heel interessante info van Discord.Dit fonds, gesticht door de rijkste Belg Eric Wittouck...	Missolapola 14 mei 2024 15:38
AFF	Forum Affimed geopend Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical OncologyThe preliminary results from the phase 2 study investigating AFM24 in c...	Missolapola 24 apr 2024 11:38
ANA	Forum Anavex Life Sciences Corp geopend Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX® 3-71 in Humanswww.anavex.com/post/anavex-life-scien...	Missolapola 24 jan 2024 13:46
AFF	Forum Affimed geopend Affimed Announces Sale of Wholly-Owned Subsidiary AbCheckMANNHEIM, Germany, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncolo...	Missolapola 3 jan 2024 12:33
ANA	Forum Anavex Life Sciences Corp geopend finance.yahoo.com/news/anavex-life-sc...Minder goeie start van 2024 voor Anavex …...	Missolapola 2 jan 2024 14:24
AFF	Forum Affimed geopend Iedereen hier een vruchtbaar beursjaar 2024 gewenst! Voor de investeerders in deze sector kan het toch bijna niet slechter worden dan het in 2023 was.Laat ons hopen dat we dit jaar de heropstanding...	Missolapola 2 jan 2024 11:41
AFF	Forum Affimed geopend Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (B...	Missolapola 11 dec 2023 12:10
AFF	Forum Affimed geopend Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer PatientsData update from AFM...	Missolapola 11 dec 2023 12:10
AFF	Forum Affimed geopend Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24Review clinical data of acimtamig in combination with cord-blood derived NK cells presented at ASH ...	Missolapola 4 dec 2023 12:40
AFF	Forum Affimed geopend Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational ProgressAcimtamig (also known as AFM13) combination with AlloNK® (also known as AB-101): Initiated LuminICE-203. Compa...	Missolapola 14 nov 2023 14:14
AFF	Forum Affimed geopend Affimed Announces Acimtamig as International Nonproprietary Name for AFM13MANNHEIM, Germany, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-st...	Missolapola 9 nov 2023 12:34
ARR	Forum Arrowhead Research geopend quote:de tuinman schreef op 28 oktober 2023 14:54:[...]Waar heb ik dit nog meer gelezen..In tien minuten zes keer een déja-vu ;-)...	Missolapola 28 okt 2023 15:14
AFF	Forum Affimed geopend Affimed Announces Listing Transfer to Nasdaq Capital MarketsMANNHEIM, Germany, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-on...	Missolapola 4 okt 2023 14:34
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate a Phase 1 Study of ARO-SOD1June 27, 2023PASADENA, Calif.--(BUSINESS WIRE)--Jun. 27, 2023-- Arrowhead Pharmaceuticals, Inc. (NAS...	Missolapola 27 jun 2023 14:39
ARR	Forum Arrowhead Research geopend ir.arrowheadpharma.com/news-releases/...Arrowhead Presents Updated Data from Phase 2 SEQUOIA Study of Investigational...	Missolapola 24 jun 2023 15:09
ANA	Forum Anavex Life Sciences Corp geopend June 1 (Reuters) - Anavex Life Sciences Corp AVXL.O : * ANAVEX ANNOUNCES ISSUANCE OF NEW U.S. INTELLECTUAL PROPERTY COMPOSITIONS PATENT FOR ANAVEX®2-73 (BLARCAMESINE) * ANAVEX LIFE SCIENCES CORP - PAT...	Missolapola 1 jun 2023 14:18
ARR	Forum Arrowhead Research geopend ir.arrowheadpharma.com/news-releases/...	Missolapola 1 jun 2023 13:39
AFF	Forum Affimed geopend Ik blijf hier zitten (GAK van $ 0,95) en wacht op een overname/verkoop/partnering.Heb het even nagekeken en op 7/7/2021 heb ik mijn ganse portefeuille met voornamelijk biotech verkocht en het is ont...	Missolapola 25 mei 2023 11:50
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals Remains A Buy For Pipeline Potential seekingalpha.com/article/4606150-arro...	Missolapola 19 mei 2023 23:13
ARR	Forum Arrowhead Research geopend Bedankt, Piddy!...	Missolapola 5 mei 2023 22:58
ARR	Forum Arrowhead Research geopend Zou er iemand een uitnodigingslink voor Discord ARWR willen plaatsen? Ik geraak er niet meer op. Alvast bedankt!...	Missolapola 5 mei 2023 20:54
ARR	Forum Arrowhead Research geopend Arrowhead delivers in the lung \| Evaluatewww.evaluate.com/vantage/articles/int...	Missolapola 26 apr 2023 18:32
ARR	Forum Arrowhead Research geopend Arrowhead Pharmaceuticals’ Proprietary Pulmonary TRiM™ Platform Achieves High Levels of Target Gene Knockdown and Long Duration of Effect \| Arrowhead Pharmaceuticals Inc. ir.arrowheadpharm...	Missolapola 25 apr 2023 14:17
AFF	Forum Affimed geopend www.goingpublic.de/life-sciences/affi...	Missolapola 31 mrt 2023 20:14
AFF	Forum Affimed geopend Truist says Fate’s reboot not a negative for Affimed 7/1/2023 - 00:00 - Reuters ** Brokerage Truist Securities says Fate Therapeutics major business reboot might be a critical point fo...	Missolapola 7 jan 2023 08:18
AFF	Forum Affimed geopend Eergisteren hier terug ingestapt. En ook bij AVXL.En voor de rest: veel ARWR ;-)...	Missolapola 5 jan 2023 20:31
ARR	Forum Arrowhead Research geopend Meanwhile AMG-890 - now known as Olpasiran - is being rushed into pivotal trials by Amgen after Phase 2 tests revealed a 90% or greater reduction in Lp(A) levels – a biomarker for cardiovascular disea...	Missolapola 13 sep 2022 10:17
ARR	Forum Arrowhead Research geopend ARO-APOC-3 is designed to reduce production of Apolipoprotein C-III - a component of triglyceride rich lipoproteins (TRLs), and its being evaluated in a Phase 3 study in patients with...	Missolapola 13 sep 2022 10:15
ARR	Forum Arrowhead Research geopend If you are therefore prepared to take Arrowheads charismatic, ambitious CEOs word for it, and continue to have faith that the TRiM platform is best in class in the RNAi field - superior, for...	Missolapola 13 sep 2022 10:11

Forumactiviteit

Lid sinds: 21 dec 2018
Laatste bezoek: 24 dec 2024
Aantal posts: 837
Gegeven aanbevelingen: 316
Ontvangen aanbevelingen: 371
Aanbevelingen/ Posts: 0,4432

Gesponsorde links

Beursduivel Premium

Verhoog uw rendement met de analyses en kooptips van Beursduivel!

Macro & Bedrijfsagenda

03 februari
1. 00:00 Beurs Shanghai gesloten (Chinees nieuwjaar)
2. 01:30 Inkoopmanagersindex industrie januari def. (Jap)
3. 06:30 Omzet detailhandel december (NL)
4. 06:30 Inflatie januari vlpg. (NL)
5. 09:00 Inkoopmanagersindex industrie januari (NL)
6. 09:15 Inkoopmanagersindex industrie januari def. (Spa)
7. 09:45 Inkoopmanagersindex industrie januari def. (Ita)
8. 09:50 Inkoopmanagersindex industrie januari def. (Fra)
9. 09:55 Inkoopmanagersindex industrie januari def. (Dld)
10. 10:00 Inkoopmanagersindex industrie januari def. (eur)

de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht

Naar de hele agenda

Inloggen

Missolapola

Top posts

Forumberichten

Forumactiviteit

Gesponsorde links

Beursduivel Premium

Macro & Bedrijfsagenda

03 februari

zoek uitleg